Arginase-1+ bone marrow myeloid cells are reduced in myeloproliferative neoplasms and correlate with clinical phenotype, fibrosis, and molecular driver.
Bonometti A, Borsani O, Rumi E, Ferretti VV, Dioli C, Lucato E, Paulli M, Boveri E. Cancer Med. 2023 Apr; 12(7):7815-7822. Epub 2022 Dec 15.